Orally Administered Vaccine and Forecast Market
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Orally Administered Vaccine
1.2 Key Market Segments
1.2.1 Orally Administered Vaccine Segment by Type
1.2.2 Orally Administered Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Orally Administered Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Orally Administered Vaccine Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Orally Administered Vaccine Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Orally Administered Vaccine Market Competitive Landscape
3.1 Global Orally Administered Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Orally Administered Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Administered Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Orally Administered Vaccine Sales Sites, Area Served, Product Type
3.6 Orally Administered Vaccine Market Competitive Situation and Trends
3.6.1 Orally Administered Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Orally Administered Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Orally Administered Vaccine Industry Chain Analysis
4.1 Orally Administered Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Orally Administered Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Orally Administered Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Orally Administered Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Orally Administered Vaccine Price by Type (2019-2024)
7 Orally Administered Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Administered Vaccine Market Sales by Application (2019-2024)
7.3 Global Orally Administered Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
8 Orally Administered Vaccine Market Consumption by Region
8.1 Global Orally Administered Vaccine Sales by Region
8.1.1 Global Orally Administered Vaccine Sales by Region
8.1.2 Global Orally Administered Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Orally Administered Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Orally Administered Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Orally Administered Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Orally Administered Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Orally Administered Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Orally Administered Vaccine Market Production by Region
9.1 Global Production of Orally Administered Vaccine by Region (2019-2024)
9.2 Global Orally Administered Vaccine Revenue Market Share by Region (2019-2024)
9.3 Global Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Orally Administered Vaccine Production
9.4.1 North America Orally Administered Vaccine Production Growth Rate (2019-2024)
9.4.2 North America Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Orally Administered Vaccine Production
9.5.1 Europe Orally Administered Vaccine Production Growth Rate (2019-2024)
9.5.2 Europe Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Orally Administered Vaccine Production (2019-2024)
9.6.1 Japan Orally Administered Vaccine Production Growth Rate (2019-2024)
9.6.2 Japan Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Orally Administered Vaccine Production (2019-2024)
9.7.1 China Orally Administered Vaccine Production Growth Rate (2019-2024)
9.7.2 China Orally Administered Vaccine Production, Revenue, Price and Gross Margin (2019-2024)
10 Key Companies Profile
10.1 Merck
10.1.1 Merck Orally Administered Vaccine Basic Information
10.1.2 Merck Orally Administered Vaccine Product Overview
10.1.3 Merck Orally Administered Vaccine Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck Orally Administered Vaccine SWOT Analysis
10.1.6 Merck Recent Developments
10.2 GSK
10.2.1 GSK Orally Administered Vaccine Basic Information
10.2.2 GSK Orally Administered Vaccine Product Overview
10.2.3 GSK Orally Administered Vaccine Product Market Performance
10.2.4 GSK Business Overview
10.2.5 GSK Orally Administered Vaccine SWOT Analysis
10.2.6 GSK Recent Developments
10.3 Sanofi
10.3.1 Sanofi Orally Administered Vaccine Basic Information
10.3.2 Sanofi Orally Administered Vaccine Product Overview
10.3.3 Sanofi Orally Administered Vaccine Product Market Performance
10.3.4 Sanofi Orally Administered Vaccine SWOT Analysis
10.3.5 Sanofi Business Overview
10.3.6 Sanofi Recent Developments
10.4 Lanzhou Institute
10.4.1 Lanzhou Institute Orally Administered Vaccine Basic Information
10.4.2 Lanzhou Institute Orally Administered Vaccine Product Overview
10.4.3 Lanzhou Institute Orally Administered Vaccine Product Market Performance
10.4.4 Lanzhou Institute Business Overview
10.4.5 Lanzhou Institute Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Orally Administered Vaccine Basic Information
10.5.2 Serum Institute Orally Administered Vaccine Product Overview
10.5.3 Serum Institute Orally Administered Vaccine Product Market Performance
10.5.4 Serum Institute Business Overview
10.5.5 Serum Institute Recent Developments
10.6 Valneva
10.6.1 Valneva Orally Administered Vaccine Basic Information
10.6.2 Valneva Orally Administered Vaccine Product Overview
10.6.3 Valneva Orally Administered Vaccine Product Market Performance
10.6.4 Valneva Business Overview
10.6.5 Valneva Recent Developments
10.7 Shanghai United Cell
10.7.1 Shanghai United Cell Orally Administered Vaccine Basic Information
10.7.2 Shanghai United Cell Orally Administered Vaccine Product Overview
10.7.3 Shanghai United Cell Orally Administered Vaccine Product Market Performance
10.7.4 Shanghai United Cell Business Overview
10.7.5 Shanghai United Cell Recent Developments
10.8 Bibcol
10.8.1 Bibcol Orally Administered Vaccine Basic Information
10.8.2 Bibcol Orally Administered Vaccine Product Overview
10.8.3 Bibcol Orally Administered Vaccine Product Market Performance
10.8.4 Bibcol Business Overview
10.8.5 Bibcol Recent Developments
10.9 PaxVax
10.9.1 PaxVax Orally Administered Vaccine Basic Information
10.9.2 PaxVax Orally Administered Vaccine Product Overview
10.9.3 PaxVax Orally Administered Vaccine Product Market Performance
10.9.4 PaxVax Business Overview
10.9.5 PaxVax Recent Developments
10.10 Vabiotech
10.10.1 Vabiotech Orally Administered Vaccine Basic Information
10.10.2 Vabiotech Orally Administered Vaccine Product Overview
10.10.3 Vabiotech Orally Administered Vaccine Product Market Performance
10.10.4 Vabiotech Business Overview
10.10.5 Vabiotech Recent Developments
10.11 Tiantan Biological
10.11.1 Tiantan Biological Orally Administered Vaccine Basic Information
10.11.2 Tiantan Biological Orally Administered Vaccine Product Overview
10.11.3 Tiantan Biological Orally Administered Vaccine Product Market Performance
10.11.4 Tiantan Biological Business Overview
10.11.5 Tiantan Biological Recent Developments
10.12 EuBiologics
10.12.1 EuBiologics Orally Administered Vaccine Basic Information
10.12.2 EuBiologics Orally Administered Vaccine Product Overview
10.12.3 EuBiologics Orally Administered Vaccine Product Market Performance
10.12.4 EuBiologics Business Overview
10.12.5 EuBiologics Recent Developments
10.13 Panacea Biotec Ltd
10.13.1 Panacea Biotec Ltd Orally Administered Vaccine Basic Information
10.13.2 Panacea Biotec Ltd Orally Administered Vaccine Product Overview
10.13.3 Panacea Biotec Ltd Orally Administered Vaccine Product Market Performance
10.13.4 Panacea Biotec Ltd Business Overview
10.13.5 Panacea Biotec Ltd Recent Developments
10.14 Bio-Med
10.14.1 Bio-Med Orally Administered Vaccine Basic Information
10.14.2 Bio-Med Orally Administered Vaccine Product Overview
10.14.3 Bio-Med Orally Administered Vaccine Product Market Performance
10.14.4 Bio-Med Business Overview
10.14.5 Bio-Med Recent Developments
10.15 Halfkin Bio-Pharmaceuticals
10.15.1 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
10.15.2 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
10.15.3 Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Market Performance
10.15.4 Halfkin Bio-Pharmaceuticals Business Overview
10.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
11 Orally Administered Vaccine Market Forecast by Region
11.1 Global Orally Administered Vaccine Market Size Forecast
11.2 Global Orally Administered Vaccine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Orally Administered Vaccine Market Size Forecast by Country
11.2.3 Asia Pacific Orally Administered Vaccine Market Size Forecast by Region
11.2.4 South America Orally Administered Vaccine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Orally Administered Vaccine by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Orally Administered Vaccine Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Orally Administered Vaccine by Type (2025-2032)
12.1.2 Global Orally Administered Vaccine Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Orally Administered Vaccine by Type (2025-2032)
12.2 Global Orally Administered Vaccine Market Forecast by Application (2025-2032)
12.2.1 Global Orally Administered Vaccine Sales (K MT) Forecast by Application
12.2.2 Global Orally Administered Vaccine Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Orally Administered Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Orally Administered Vaccine Sales (K MT) by Manufacturers (2019-2024)
Table 6. Global Orally Administered Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Orally Administered Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Orally Administered Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Administered Vaccine as of 2022)
Table 10. Global Market Orally Administered Vaccine Average Price (USD/MT) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Orally Administered Vaccine Sales Sites and Area Served
Table 12. Manufacturers Orally Administered Vaccine Product Type
Table 13. Global Orally Administered Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Orally Administered Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orally Administered Vaccine Market Challenges
Table 22. Global Orally Administered Vaccine Sales by Type (K MT)
Table 23. Global Orally Administered Vaccine Market Size by Type (M USD)
Table 24. Global Orally Administered Vaccine Sales (K MT) by Type (2019-2024)
Table 25. Global Orally Administered Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Orally Administered Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Orally Administered Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Orally Administered Vaccine Price (USD/MT) by Type (2019-2024)
Table 29. Global Orally Administered Vaccine Sales (K MT) by Application
Table 30. Global Orally Administered Vaccine Market Size by Application
Table 31. Global Orally Administered Vaccine Sales by Application (2019-2024) & (K MT)
Table 32. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Orally Administered Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Table 35. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Orally Administered Vaccine Sales by Region (2019-2024) & (K MT)
Table 37. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Orally Administered Vaccine Sales by Country (2019-2024) & (K MT)
Table 39. Europe Orally Administered Vaccine Sales by Country (2019-2024) & (K MT)
Table 40. Asia Pacific Orally Administered Vaccine Sales by Region (2019-2024) & (K MT)
Table 41. South America Orally Administered Vaccine Sales by Country (2019-2024) & (K MT)
Table 42. Middle East and Africa Orally Administered Vaccine Sales by Region (2019-2024) & (K MT)
Table 43. Global Orally Administered Vaccine Production (K MT) by Region (2019-2024)
Table 44. Global Orally Administered Vaccine Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Orally Administered Vaccine Revenue Market Share by Region (2019-2024)
Table 46. Global Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 47. North America Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 48. Europe Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 49. Japan Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 50. China Orally Administered Vaccine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 51. Merck Orally Administered Vaccine Basic Information
Table 52. Merck Orally Administered Vaccine Product Overview
Table 53. Merck Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 54. Merck Business Overview
Table 55. Merck Orally Administered Vaccine SWOT Analysis
Table 56. Merck Recent Developments
Table 57. GSK Orally Administered Vaccine Basic Information
Table 58. GSK Orally Administered Vaccine Product Overview
Table 59. GSK Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. GSK Business Overview
Table 61. GSK Orally Administered Vaccine SWOT Analysis
Table 62. GSK Recent Developments
Table 63. Sanofi Orally Administered Vaccine Basic Information
Table 64. Sanofi Orally Administered Vaccine Product Overview
Table 65. Sanofi Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 66. Sanofi Orally Administered Vaccine SWOT Analysis
Table 67. Sanofi Business Overview
Table 68. Sanofi Recent Developments
Table 69. Lanzhou Institute Orally Administered Vaccine Basic Information
Table 70. Lanzhou Institute Orally Administered Vaccine Product Overview
Table 71. Lanzhou Institute Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 72. Lanzhou Institute Business Overview
Table 73. Lanzhou Institute Recent Developments
Table 74. Serum Institute Orally Administered Vaccine Basic Information
Table 75. Serum Institute Orally Administered Vaccine Product Overview
Table 76. Serum Institute Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 77. Serum Institute Business Overview
Table 78. Serum Institute Recent Developments
Table 79. Valneva Orally Administered Vaccine Basic Information
Table 80. Valneva Orally Administered Vaccine Product Overview
Table 81. Valneva Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 82. Valneva Business Overview
Table 83. Valneva Recent Developments
Table 84. Shanghai United Cell Orally Administered Vaccine Basic Information
Table 85. Shanghai United Cell Orally Administered Vaccine Product Overview
Table 86. Shanghai United Cell Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 87. Shanghai United Cell Business Overview
Table 88. Shanghai United Cell Recent Developments
Table 89. Bibcol Orally Administered Vaccine Basic Information
Table 90. Bibcol Orally Administered Vaccine Product Overview
Table 91. Bibcol Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 92. Bibcol Business Overview
Table 93. Bibcol Recent Developments
Table 94. PaxVax Orally Administered Vaccine Basic Information
Table 95. PaxVax Orally Administered Vaccine Product Overview
Table 96. PaxVax Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 97. PaxVax Business Overview
Table 98. PaxVax Recent Developments
Table 99. Vabiotech Orally Administered Vaccine Basic Information
Table 100. Vabiotech Orally Administered Vaccine Product Overview
Table 101. Vabiotech Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 102. Vabiotech Business Overview
Table 103. Vabiotech Recent Developments
Table 104. Tiantan Biological Orally Administered Vaccine Basic Information
Table 105. Tiantan Biological Orally Administered Vaccine Product Overview
Table 106. Tiantan Biological Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 107. Tiantan Biological Business Overview
Table 108. Tiantan Biological Recent Developments
Table 109. EuBiologics Orally Administered Vaccine Basic Information
Table 110. EuBiologics Orally Administered Vaccine Product Overview
Table 111. EuBiologics Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 112. EuBiologics Business Overview
Table 113. EuBiologics Recent Developments
Table 114. Panacea Biotec Ltd Orally Administered Vaccine Basic Information
Table 115. Panacea Biotec Ltd Orally Administered Vaccine Product Overview
Table 116. Panacea Biotec Ltd Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 117. Panacea Biotec Ltd Business Overview
Table 118. Panacea Biotec Ltd Recent Developments
Table 119. Bio-Med Orally Administered Vaccine Basic Information
Table 120. Bio-Med Orally Administered Vaccine Product Overview
Table 121. Bio-Med Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 122. Bio-Med Business Overview
Table 123. Bio-Med Recent Developments
Table 124. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Basic Information
Table 125. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Product Overview
Table 126. Halfkin Bio-Pharmaceuticals Orally Administered Vaccine Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2024)
Table 127. Halfkin Bio-Pharmaceuticals Business Overview
Table 128. Halfkin Bio-Pharmaceuticals Recent Developments
Table 129. Global Orally Administered Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 130. Global Orally Administered Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 131. North America Orally Administered Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 132. North America Orally Administered Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 133. Europe Orally Administered Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 134. Europe Orally Administered Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 135. Asia Pacific Orally Administered Vaccine Sales Forecast by Region (2025-2032) & (K MT)
Table 136. Asia Pacific Orally Administered Vaccine Market Size Forecast by Region (2025-2032) & (M USD)
Table 137. South America Orally Administered Vaccine Sales Forecast by Country (2025-2032) & (K MT)
Table 138. South America Orally Administered Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 139. Middle East and Africa Orally Administered Vaccine Consumption Forecast by Country (2025-2032) & (Units)
Table 140. Middle East and Africa Orally Administered Vaccine Market Size Forecast by Country (2025-2032) & (M USD)
Table 141. Global Orally Administered Vaccine Sales Forecast by Type (2025-2032) & (K MT)
Table 142. Global Orally Administered Vaccine Market Size Forecast by Type (2025-2032) & (M USD)
Table 143. Global Orally Administered Vaccine Price Forecast by Type (2025-2032) & (USD/MT)
Table 144. Global Orally Administered Vaccine Sales (K MT) Forecast by Application (2025-2032)
Table 145. Global Orally Administered Vaccine Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Orally Administered Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orally Administered Vaccine Market Size (M USD), 2019-2032
Figure 5. Global Orally Administered Vaccine Market Size (M USD) (2019-2032)
Figure 6. Global Orally Administered Vaccine Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orally Administered Vaccine Market Size by Country (M USD)
Figure 11. Orally Administered Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Orally Administered Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Orally Administered Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Orally Administered Vaccine Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Orally Administered Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Orally Administered Vaccine Market Share by Type
Figure 18. Sales Market Share of Orally Administered Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Orally Administered Vaccine by Type in 2023
Figure 20. Market Size Share of Orally Administered Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Orally Administered Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Orally Administered Vaccine Market Share by Application
Figure 24. Global Orally Administered Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Orally Administered Vaccine Sales Market Share by Application in 2023
Figure 26. Global Orally Administered Vaccine Market Share by Application (2019-2024)
Figure 27. Global Orally Administered Vaccine Market Share by Application in 2023
Figure 28. Global Orally Administered Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Orally Administered Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 31. North America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 33. Canada Orally Administered Vaccine Sales (K MT) and Growth Rate (2019-2024)
Figure 34. Mexico Orally Administered Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 36. Europe Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 38. France Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 39. U.K. Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 40. Italy Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 41. Russia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 42. Asia Pacific Orally Administered Vaccine Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 44. China Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 45. Japan Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 46. South Korea Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 47. India Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 48. Southeast Asia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 49. South America Orally Administered Vaccine Sales and Growth Rate (K MT)
Figure 50. South America Orally Administered Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 52. Argentina Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 53. Columbia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 54. Middle East and Africa Orally Administered Vaccine Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Orally Administered Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 57. UAE Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 58. Egypt Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 59. Nigeria Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 60. South Africa Orally Administered Vaccine Sales and Growth Rate (2019-2024) & (K MT)
Figure 61. Global Orally Administered Vaccine Production Market Share by Region (2019-2024)
Figure 62. North America Orally Administered Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 63. Europe Orally Administered Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 64. Japan Orally Administered Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 65. China Orally Administered Vaccine Production (K MT) Growth Rate (2019-2024)
Figure 66. Global Orally Administered Vaccine Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Orally Administered Vaccine Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Orally Administered Vaccine Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Orally Administered Vaccine Market Share Forecast by Type (2025-2032)
Figure 70. Global Orally Administered Vaccine Sales Forecast by Application (2025-2032)
Figure 71. Global Orally Administered Vaccine Market Share Forecast by Application (2025-2032)
